Janney Montgomery Scott LLC Sells 200 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Janney Montgomery Scott LLC reduced its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 4.0% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 4,855 shares of the company’s stock after selling 200 shares during the period. Janney Montgomery Scott LLC’s holdings in VanEck Pharmaceutical ETF were worth $442,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of PPH. Jones Financial Companies Lllp raised its position in VanEck Pharmaceutical ETF by 1,827.0% in the fourth quarter. Jones Financial Companies Lllp now owns 5,704 shares of the company’s stock worth $492,000 after acquiring an additional 5,408 shares during the period. SBI Securities Co. Ltd. purchased a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter worth $29,000. Steward Partners Investment Advisory LLC raised its holdings in VanEck Pharmaceutical ETF by 218.3% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 21,738 shares of the company’s stock worth $1,876,000 after purchasing an additional 14,908 shares during the period. Raymond James Financial Inc. bought a new position in VanEck Pharmaceutical ETF in the 4th quarter worth $1,323,000. Finally, Independent Advisor Alliance lifted its position in VanEck Pharmaceutical ETF by 19.8% during the fourth quarter. Independent Advisor Alliance now owns 58,398 shares of the company’s stock valued at $5,039,000 after purchasing an additional 9,647 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Down 0.4%

Shares of PPH opened at $88.06 on Friday. The business has a 50-day simple moving average of $87.66 and a two-hundred day simple moving average of $88.08. The stock has a market cap of $633.12 million, a price-to-earnings ratio of 20.21 and a beta of 0.72. VanEck Pharmaceutical ETF has a 52 week low of $77.67 and a 52 week high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 7th. Investors of record on Tuesday, July 1st will be issued a $0.6069 dividend. This represents a $2.43 annualized dividend and a yield of 2.76%. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Tuesday, July 1st.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.